Expression of cyclin e in resting and activated B-chronic lymphocytic leukaemia cells: Cyclin E/cdk2 as a potential therapeutic target

British Journal of Haematology

Volumn 125, Issue 2, 2004, Pages 141-148

  Decker, Thomas ^a   Hipp, Susanne ^a   Hahntow, Ines ^a   Schneller, Folker ^a   Peschel, Christian ^a  

^a TECHNICAL UNIVERSITY OF MUNICH   (Germany)

Author keywords

B cell chronic lymphocytic leukaemia; Cell cycle; Cycline E; p27; Roscovitine

Indexed keywords

CYCLIN DEPENDENT KINASE 2; CYCLIN DEPENDENT KINASE INHIBITOR; CYCLIN E; HISTONE H1; INTERLEUKIN 2; OLIGODEOXYNUCLEOTIDE; PROTEIN P27; ROSCOVITINE; THYMIDINE;

ANTIGEN EXPRESSION; ANTIGEN PURIFICATION; ARTICLE; B LYMPHOCYTE; BLOOD SAMPLING; CELL CYCLE; CELL DEATH; CELL PROLIFERATION; CELL STIMULATION; CHRONIC LYMPHATIC LEUKEMIA; COMPLEX FORMATION; CONTROLLED STUDY; DETERIORATION; HUMAN; HUMAN CELL; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; REACTIVE INHIBITION; REGULATORY MECHANISM; WESTERN BLOTTING;

AGED; AGED, 80 AND OVER; BLOTTING, WESTERN; CDC2-CDC28 KINASES; CELL CYCLE; CELL CYCLE PROTEINS; CYCLIN E; CYCLIN-DEPENDENT KINASE 2; CYCLIN-DEPENDENT KINASE INHIBITOR P27; ENZYME INHIBITORS; FEMALE; HUMANS; LEUKEMIA, B-CELL, CHRONIC; MALE; MIDDLE AGED; PURINES; TUMOR SUPPRESSOR PROTEINS;

EID: 2042436415     PISSN: 00071048     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1365-2141.2004.04901.x     Document Type: Article

References (38)

1. Bain, J., McLauchlan, H., Elliott, M. & Cohen, P. (2003) The specificities of protein kinase inhibitors: an update. Biochemistry Journal, 371, 199-204.
2. Caligaris-Cappio, F. (2003) Role of the microenvironment in chronic lymphocytic leukemia. British tournai of Haematology, 123, 380-388.
3. Cobo, F., Martinez, A., Pinyol, M., Hernendez, L., Gomez, M., Bea, S., Esteve, J., Rozman, M., Bosch, F., Lopez-Guilermo, A., Montserrat, E. & Campo, E. (2002) Multiple cell cycle regulator alterations in Richter's transformation of chronic lymphocytic leukemia. Leukemia, 16, 1028-1034.
4. Crespo, M., Bosch, F., Villamor, N., Bellosillo, B., Colomer, D., Rozman, M., Marce, S., Lopez-Guilermo, A., Campo, E. & Montserrat, E. (2003) ZAP-70 expression as a surrogate for immunoglobulin-variable region mutations in chronic lymphocytic leukemia. New England Journal of Medicine, 348, 1764-1775.
5. David-Pfeuty, T. (1999) Potent inhibitors of cyclin-dependent kinase 2 induce nuclear accumulation of wild-type p53 and nuclear fragmentation in human untransformed and tumor-derived cells. Oncogene, 18, 7409-7422.
6. Decker, T., Schneller, F., Hipp, S., Miething, C., Jahn, T., Duyster, J. & Peschel, C. (2002) Cell cycle progression of chronic lymphocytic leukemia cells is controlled by cyclin D2, cyclin D3, cyclin dependent kinase (cdk) 4 and the cdk inhibitor p27. Leukemia, 16, 327-334.
7. Decker, T., Hipp, S., Ringshausen, I., Bogner, C., Oelsner, M., Schneller, F. & Peschel, C. (2003) Rapamycin-induced G1 arrest in cycling B-CLL cells is associated with reduced expression of cyclin D3, cyclin E, cyclin A, and survivin. Blood, 101, 278-285.
8. Edamatsu, H., Gau, C.L., Nemoto, T., Guo, L. & Tamanoi, F. (2000) Cdk inhibitors, roscovitine and olomoucine, synergize with farnesyltransferase inhibitors (FTI) to induce efficient apoptosis of human cancer cell lines. Oncogene, 19, 3059-3068.
9. Erlandsson, F., Wahlby, C., Ekholm-Reed, S., Hellstrom, A.C., Bengtsson, E. & Zetterberg, A. (2003) Abnormal expression pattern of cyclin E in tumour cells. International Journal of Cancer, 104, 369-375.
10. Erlanson, M., Portin, C., Linderholm, B., Lindh, J., Roos, G. & Landberg, G. (1998) Expression of cyclin E and the cyclin-dependent kinase inhibitor p27 in malignant lymphomas - prognostic implications. Blood, 92, 770-777.
11. Ferreri, A.J., Ponzoni, M., Pruneti, G., Freschi, M., Rossi, R., Dell'Oro, S., Baldini, L., Buffa, R., Carboni, N., Villa, E. & Viale, G. (2001) Immunoreactivity for p27(KIP1) and cyclin E is an independent predictor of survival in primari gastric non-Hodgkin's lymphoma. International Journal of Cancer, 15, 599-604.
12. Granziero, L., Ghia, P., Circosta, P., Gottardi, D., Strola, G., Geuna, M., Montagna, L., Piccoli, P., Chilosi, M. & Caligaris-Cappio, F. (2001) Survivin is expressed on CD40 stimulation and interfaces proliferation and apoptosis in B-cell chronic lymphocytic leukemia. Blood, 97, 2777-2783.
13. Iida, H., Towatari, M., Tanimoto, M., Morishita, Y., Kodera, Y. & Saito, H. (1997) Overexpression of cyclin E in acute myelogenous leukemia. Blood, 90, 3707-3713.
14. Keyomarsi, K., Tucker, S.L., Buchholz, T.A., Callister, M., Ding, Y., Hortobagyi, G.N., Bedrosian, I., Knickerbocker, C., Toyofuku, W., Lowe, M., Herlicek, T. & Bacus, S.S. (2002) Cyclin E and survival in patients with breast cancer. New England Journal of Medicine, 347, 1566-1575.
15. Kitada, S., Andresen, J., Akar, S., Zapata, J.M., Takayama, S., Krajewski, S., Wang, H.G., Zhang, C.M., Rai, K., Hines, J. & Reed, J.C. (1998) Expression of apoptosis-regulating proteins in chronic lymphocytic leukemia: correlations with in vitro and in vivo chemoresponses. Blood, 91, 3379-3389.
16. McClue, S.J., Blake, D., Clarke, R., Cowan, A., Cummings, L., Fischer, P.M., MacKenzie, M., Melville, J., Stewart, K., Wang, S., Zheleva, D. & Lane, D.P. (2002) In vitro and in vivo antitumor properties of the cyclin dependent kinase inhibitor CYC202 (R-roscovitine). International Journal of Cancer, 102, 463-468.
17. Meijer, L., Borgne, A., Mulner, O., Chong, J.P.J., Blow, J., Inagaki, N., Inagaki, M., Delcros, J.G. & Moulinoux, J.P. (1997) Biochemical and cellular effects of roscovitine, a potent and selective inhibitor of the cyclin-dependent kinases cdc2, cdk2 and cdk5. European Journal of Biochemistry, 243, 527-536.
18. Messmer, D., Messmer, B.D., Cesar, D., Albesiano, E., Telusma, G., Damle, R., Allen, S.L., Kudulkar, P., Kolitz, J.E., Loscalzo, J., Ho, C., Rai, K.R., Hellerstein, M. & Chiorazzi, N. (2002) Direct measurement of B-CLL cell production and turnover in vivo. Blood, 100, 634a.
19. Mgbonyebi, O.P., Russo, J. & Russo, H.I. (1999) Roscovitine induces cell death and morphological changes indicative of apoptosis in MDA-MB-231 breast cancer cells. Cancer Research, 15, 1903-1910.
20. Mishina, T., Dosaka-Akita, H., Hommura, F., Nishi, M., Kojima, T., Ogura, S., Shimizu, M., Katoh, H. & Kawakami, Y. (2000) Cyclin E expression, a potential prognostic marker for non-small cell lung cancers. Clinical Cancer Research, 6, 11-16.
21. Nourse, J., Firpo, E., Flanagan, W.M., Coats, S., Polyak, K., Lee, H.M., Massague, J., Crabtree, G.R. & Roberts, J.M. (1994) Interleukin-2-mediated elimination of the p27kip1 cyclin-dependent kinase inhibitor is prevented by rapamycin. Nature, 372, 570-573.
22. Pierga, J.Y., Faivre, S., Vera, K., Laurence, V., Delbaldo, C., Bekradda, M., Armand, J.-P., Gianella-Borradori, A., Dieras, V. & Raymond, E. (2003) A phase I and pharmakokoneitic (pk) trial of Cyc202, a novel oral cyclin-dependent kinase (cdk) inhibitor, in patients with advanced solid tumors. Proceedings of the American Society of Clinical Oncology, 22 (Abstract 840).
23. Porter, P., Malone, K.E., Hengerty, P.J., Alexander, G.M., Gatti, L.A., Firpo, E.J., Daling, J.R. & Roberts, J.M. (1997) Expression of cell cycle regulators p27kip1 and cyclin E, alone and in combination, correlate with survival in young breast cancer patients. Nature Medicine, 3, 222-226.
24. Porter, D.C., Zhang, N., Danes, C., McGahren, M.J., Harwell, R.M., Faruki, S. & Keyomarsi, K. (2001) Tumor-specific proteoloytic processing of cyclin E generates hyperactive lower-molecular-weight forms. Molecular and Cellular Biology, 21, 6254-6259.
25. Qintanilla-Martínez, L., Thieblemont, C., Fend, F., Kumar, S., Pinyol, M., Campo, E., Jaffe, E.S. & Raffeld, M. (1998) Mantle cell lymphoma lack expression of p27kip1, a cyclin-dependent kinase inhibitor. American Journal of Pathology, 153, 175-182.
26. Ringshausen, I., Schneller, F., Bogner, C., Hipp, S., Duyster, J., Peschel, C. & Decker, T. (2002) Constitutively activated phosphatidylinositol-3 kinase is involved in the defect of apoptosis in B-CLL: association with protein kinase Cdelta. Blood, 100, 3741-3748.
27. Scuderi, R., Palucka, K.A., Pokrovskaja, K., Bjorkhol, M., Wiman, K.G. & Pisa, P. (1996) Cyclin E overexpression in relapsed adult acute lymphoblastic leukemias of B cell lineage. Blood, 87, 3360-3367.
28. Senderowicz, A.M. & Sausville, E.A. (2000) Preclinical and clinical development of cyclin-dependent kinase modulators. Journal of the National Cancer Institute, 92, 376-387.
29. Sherr, C. (1994) G1 phase progression: cycling on cue. Cell, 79, 551-555.
30. Sherr, C.J. (2000) The pezcoller lecture: cancer cell cycles revisited. Cancer Research, 60, 3689-3695.
31. Tan, A.R., Headlee, D., Messmann, R., Sausville, E.A., Arbuck, S.G., Murgo, A.J., Melillo, G., Zhai, S., Figg, W.D., Swain, S.M. & Senderowicz, A.M. (2002) Phase I clinical and pharmacokinetic study of flavopiridol administered as a daily 1-hour infusion in patients with advanced neoplasms. Journal of Clinical Oncology, 20, 4074-4082.
32. Vesely, J., Havlicek, L., Strnad, M., Blow, J.J., Donella-Deana, A., Pinna, L., Letham, D.S., Kato, J., Detivaud, L., Leclerc, S. & Meijer, L. (1994) Inhibition of cycli-dependent kinases by purine analogues. European Journal of Biochemistry, 224, 771-786.
33. Vrhovac, R., Delmer, A., Tang, R., Marie, J.P., Zittuon, R. & Ajchenbaum-Cymbalista, F. (1998) Prognostic Significance of the cell cycle inhibitor p27 in chronic B-cell lymphocytic leukemia. Blood, 91, 4694-4700.
34. Wagner, E.F., Hleb, M., Hanna, N. & Sharma, S. (1998) A pivotal role of cyclin D3 and cyclin-dependent kinase inhibitor p27 in the regulation of IL-2, IL-4- or IL-10-mediated human B cell proliferation. Journal of Immunology, 161, 1123-1131.
35. Wang, X.D., Rosales, J.L., Magliocco, A., Gnanakumar, R. & Lee, K.Y. (2003) Cyclin E in breast tumors is cleaved into its low molecular weight forms by calpain. Oncogene, 22, 769-774.
36. Witkowski, J.M., Zmuda-Trzebiatowska, E., Swiercz, J.M., Cichorek, M., Ciepluch, H., Lewandowski, K., Bryl, E. & Hellmann, A. (2002) Modulation of the activity of calcium-activated neutral proteases (calpains) in chronic lymphocytic leukemia (B-CLL) cells. Blood, 100, 1802-1809.
37. Wolowiec, D., Benchaib, M., Pernas, P., Deviller, P., Souchier, C., Rimokh, R., Felman, P., Bryon, P.A. & Frech, M. (1995) Expression of cell cycle regulatory proteins in chronic lymphocytic leukemias. Comparison with non-Hodgkin's lymphomas and non-neoplastic tissue. Leukemia, 5, 1382-1388.
38. Xiangming, C., Natsugoe, S., Takak, S., Hokita, S., Tanabe, G., Baba, M., Kuroshima, K. & Aikou, T. (2000) The cooperative role of p27 with cyclin E in the prognosis of advanced gastric carcinoma. Cancer, 89, 1214-1219.